Most Recent
A judge on Friday slugged Westpac with a $40 million penalty for charging advice fees to over 11,800 dead customers in the last of six cases brought by the corporate regulator, taking the total to be paid by the bank to $113 million.
Telecommunications giant SingTel is challenging a ruling in favour of the Australian Taxation Office's decision to reject over $894,000 in tax deductions related to its $14.2 billion acquisition of Optus.
A Gold Coast cosmetic surgeon has won his defamation case against a competitor who posted a phony online review, with a judge ordering damages of more than $450,000.
A former Deloitte director accused of embezzling $3.1 million has agreed to court orders that he repay the money and hand over title to all assets -- including almost 100 works of art -- purchased with the alleged misappropriated funds.
HWL Ebsworth managing partner Juan Martinez is yet again the target of a lawsuit, the latest claiming he committed a "fundamental breach" by locking a capital partner out of the office and withholding profits after the partner gave notice.
Deloitte has secured a freezing order on the assets and bank accounts of a director accused of stealing funds from the consulting giant, in what a judge has described as an alleged "remarkable fraud".
Almost half of the $3 million in legal costs incurred by former Tennis Australia president Steven Healy in successfully defending against the regulator's case over the broadcast rights to the Open were for "luxuries of litigation" that he should pay for himself, ASIC has told a court.
The trustee of Mayfair Group's collapsed IPO Wealth Fund has reached an in-principle settlement in a class action alleging it misled investors, who lost $86 million when the fund was wound up.
The High Court has rejected a special leave application by consumer goods giant Reckitt-Benckiser in its long-running battle with the maker of painkiller Maxigesic.
The Full Federal Court won't give Swiss pharmaceuticals giant Novartis the chance to appeal a ruling that threw out three of its four experts in a patent case against generic drug maker Pharmacor.